Trial intelligence / Profile preview

Tacrolimus disposition in pediatric liver transplantation

2013-000615-24Phase 4Terminated

Sponsor
Cliniques universitaires Saint-Luc
Start
Feb 2014
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of tacrolimus in liver transplant, sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Area Under the time-concentration Curve (AUC) for tacrolimus. Started Feb 2014; status: terminated.

02

Drugs

tacrolimus
03

Conditions

liver transplant

Beyond the preview

Go deeper on 2013-000615-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000615-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call